한빛사논문 | BRIC

심만규 님의 논문 목록

한국과학기술연구원 (KIST)

CV File 94 kb

Drug repositioning of mesalamine via supramolecular nanoassembly for the treatment of drug-induced acute liver failure
- Theranostics, 2025; 15(3):1122-1134 | https://www.thno.org/v15p1122
- 2025-01
- 바이오·의료융합
- 한빛사논문
Self-assembled Peptide-derived Proteolysis-targeting Chimera (PROTAC) Nanoparticles for Tumor-targeted and Durable PD-L1 Degradation in Cancer Immunotherapy
- Angew. Chem.-Int. Edit., Nov 21 2024, | https://doi.org/10.1002/anie.202414146
- 2024-11
- 바이오·의료융합
- 한빛사논문
Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs
- Theranostics, Published 2024-8-26;14(14):5413-5428 | doi:10.7150/thno.97269
- 2024-08
- 바이오·의료융합
- 한빛사논문
Oral Delivery of Photoresponsive Milk-Derived Exosomes for the Local Therapy of Glioblastoma
- ACS Mater. Lett., July 31, 2024; 6,4019-4027 | https://doi.org/10.1021/acsmaterialslett.4c01122
- 2024-07
- 바이오·의료융합
- 한빛사논문
Light-Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy
- Adv. Mater., Jun 19 2024, | https://doi.org/10.1002/adma.202405475
- 2024-06
- 바이오·의료융합
- 한빛사논문
Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease
- ACS Nano, June 12, 2024 | https://doi.org/10.1021/acsnano.4c05544
- 2024-06
- 바이오·의료융합
- 한빛사논문
Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy
- J. Control. Release, 2019 Jan 28:294:376-389 | https://doi.org/10.1016/j.jconrel.2018.11.032
- 2019-01
- 바이오·의료융합
- 상위피인용논문
Accurately controlled tumor temperature with silica-coated gold nanorods for optimal immune checkpoint blockade therapy
- Biomater. Res., 27 Mar 2024 | https://spj.science.org/doi/10.34133/bmr.0024
- 2024-03
- 바이오·의료융합
- 한빛사논문
Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy
- J. Nanobiotechnol., Mar 13 2024, 22 (1) 109 | https://doi.org/10.1186/s12951-024-02314-w
- 2024-03
- 바이오·의료융합
- 한빛사논문
Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy
- Acta Pharm. Sin. B, Available online 19 September 2023 | https://doi.org/10.1016/j.apsb.2023.09.007
- 2023-09
- 바이오·의료융합
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기